State of Alaska Department of Revenue’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$407K Sell
39,989
-16,404
-29% -$156K ﹤0.01% 1479
2026
Q1
$505K Buy
56,393
+9,070
+19% +$72.3K 0.01% 1415
2025
Q4
$285K Sell
47,323
-208
-0.4% -$1.24K ﹤0.01% 1597
2025
Q3
$271K Sell
47,531
-7,545
-14% -$38.6K ﹤0.01% 1549
2025
Q2
$277K Buy
55,076
+3,948
+8% +$21.2K ﹤0.01% 1524
2025
Q1
$331K Sell
51,128
-151,313
-75% -$1.35M ﹤0.01% 1480
2024
Q4
$1.49M Buy
202,441
+50,199
+33% +$396K 0.02% 847
2024
Q3
$1.14M Buy
152,242
+1,117
+0.7% +$9.7K 0.01% 997
2024
Q2
$1.34M Sell
151,125
-1,322
-0.9% -$12.7K 0.02% 850
2024
Q1
$1.54M Sell
152,447
-518
-0.3% -$5.28K 0.02% 808
2023
Q4
$1.54M Sell
152,965
-529
-0.3% -$4.83K 0.02% 791
2023
Q3
$1.44M Buy
153,494
+103,246
+205% +$1.47M 0.02% 773
2023
Q2
$1.23M Sell
50,248
-1,711
-3% -$43K 0.01% 872
2023
Q1
$1.21M Sell
51,959
-875
-2% -$22.4K 0.01% 873
2022
Q4
$1.34M Buy
52,834
+491
+0.9% +$12K 0.02% 813
2022
Q3
$1.01M Sell
52,343
-3,732
-7% -$94.9K 0.01% 904
2022
Q2
$1.43M Buy
+56,075
New +$1.31M 0.02% 773

Other funds holding VIR

State of Alaska Department of Revenue's VIR Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its Vir Biotechnology (VIR) stake by 29% in Q2 2026, selling an estimated $156K and leaving 39,989 shares worth $407K. The position accounts for ﹤0.01% of the portfolio, ranked #1479.

State of Alaska Department of Revenue first reported a position in VIR in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.54M in Q1 2024. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • State of Alaska Department of Revenue held 39,989 shares of Vir Biotechnology worth $407K as of Q2 2026.
  • State of Alaska Department of Revenue sold 16,404 Vir Biotechnology shares in Q2 2026, an estimated $156K.
  • Vir Biotechnology made up ﹤0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1479 holding.
  • State of Alaska Department of Revenue first reported a position in Vir Biotechnology in Q2 2022 and has held it in 17 quarters since.
  • State of Alaska Department of Revenue's Vir Biotechnology position peaked at $1.54M in Q1 2024.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.